Nurse Practitioner, Family · Ripley, MS
NPI
1245638642
Since 2014
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1331 City Ave N
Ripley, MS, 38663
Phone (662) 993-9336
Groups this clinician bills Medicare through
Medicare paid, 2023
$5,523
255 services
Medicare patients, 2023
100
Average age 72
Drug cost, 2024
$2.4M
7,541 prescriptions
Company payments, 2025
$462
From 9 companies
Procedures and visits billed to Original Medicare, 2023
In 2023, the most common Medicare service billed by Whitney L Walker was code 71046 (x-ray - chest), 41 times for 20 patients. In total Whitney L Walker billed 255 services in 26 codes, and Medicare paid $5,523.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-12-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 71046 X-ray - Chest | Office | 41 | 20 | $6.23 | $255 |
| 81003 Clinical Chemistry | Office | 38 | 32 | $2.20 | $83.6 |
| 87635 COVID Specific | Office | 35 | 34 | $48.84 | $1,710 |
| 87502 Infectious Agent Detection by DNA/RNA | Office | 24 | 23 | $89.97 | $2,159 |
| 87651 Infectious Agent Detection by DNA/RNA | Office | 19 | 19 | $32.58 | $619 |
| 83036 Blood Count | Office | 12 | 12 | $9.25 | $111 |
By year: 2022 $13K for 574 services; 2023 $5,523 for 255 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 38 | 32 | $2.20 | $83.6 |
| 87635 COVID Specific | 35 | 34 | $48.84 | $1,710 |
| 87502 Infectious Agent Detection by DNA/RNA | 24 | 23 | $89.97 | $2,159 |
| 87651 Infectious Agent Detection by DNA/RNA | 19 | 19 | $32.58 | $619 |
| 83036 Blood Count | 12 | 12 | $9.25 | $111 |
Medicare prescription drug claims, 2024
In 2024, the drug Whitney L Walker prescribed most often to Medicare patients was Rosuvastatin Calcium, with 291 prescriptions and refills. In total Whitney L Walker wrote 7,541 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 291 | 688 | 83 | $2,273 |
| Ozempic Semaglutide | 206 | 306 | 41 | $283K |
| Atorvastatin Calcium Generic | 182 | 503 | 60 | $1,106 |
| Amlodipine Besylate Generic | 169 | 448 | 54 | $481 |
| Lisinopril Generic | 167 | 448 | 50 | $949 |
| Gabapentin Generic | 167 | 367 | 52 | $2,444 |
| Losartan Potassium Generic | 153 | 393 | 44 | $1,136 |
| Eliquis Apixaban | 152 | 439 | 60 | $249K |
| Farxiga Dapagliflozin Propanediol | 146 | 392 | 48 | $218K |
| Omeprazole Generic | 146 | 352 | 39 | $714 |
| Famotidine Generic | 146 | 354 | 39 | $1,301 |
| Pantoprazole Sodium Generic | 145 | 374 | 47 | $1,028 |
| Levothyroxine Sodium Generic | 141 | 389 | 45 | $1,080 |
| Ezetimibe Generic | 125 | 351 | 35 | $1,777 |
| Montelukast Sodium Generic | 120 | 286 | 35 | $707 |
Brand drugs: 2,034 claims; generic drugs: 5,458 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Whitney L Walker $462 ($462 in general payments such as food, travel and fees) from 9 companies. The largest payer was Boston Scientific Corporation with $132.
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation BSX | 2 | $132 |
| Lilly USA, LLC LLY | 4 | $65.27 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $62.74 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $55.41 |
| Abbott Laboratories ABT | 3 | $43.52 |
| IBSA Pharma Inc. | 2 | $31.65 |
| Amgen Inc. AMGN | 2 | $29.52 |
| GlaxoSmithKline, LLC. GSK | 1 | $21.62 |
| Esperion Therapeutics, Inc. ESPR | 1 | $20.76 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.